Echocardiography indicated an increased ejection fraction in the bFGF group (64 ± 2.4%) compared with the MI group (47 ± 4.9%) and bFGF + 2-MeOE2 group (45 ± 6.5%) after treatment for 7 and 28 days (Figure 1). This evidence concerns the gene FGF2 and myocardial infarction.